Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.

Clinical trial NCT07645534 · RECRUITING

Trial details

NCT number: NCT07645534
Sponsor: Valenta Pharm JSC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza Acute Respiratory Viral Infections

Start date: 2025-07-11
Primary completion: 2027-12-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.